New Key Statistics Module, Z-Score and F-Score
NAS:KTTA Key Ratios
Market Cap $ M | 6.68 |
Enterprise Value $ M | -5.30 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.34 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -13.91 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.32 |
EV-to-EBITDA | 0.33 |
PEG | -- |
Shares Outstanding M | 1.04 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 5.35 |
Current Ratio | 5.35 |
ROA % (ttm) | -51.09 |
ROE % (ttm) | -55.63 |
ROIC % (ttm) | -165.31 |
Dividend Yield % | -- |
Altman Z-Score | -- |
KTTA Number of Guru Trades
KTTA Volume of Guru Trades
Gurus Latest Trades with NAS:KTTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KTTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pasithea Therapeutics Corp Insider Transactions
No Available Data
News about NAS:KTTA
Total 0- 1